HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dietary Fiber Alternative Definition Floated By CHPA

This article was originally published in The Tan Sheet

Executive Summary

A single, "all-inclusive" definition for dietary fiber would be preferable to the "two-prong" approach proposed by a panel of the Food & Nutrition Board, the Consumer Healthcare Products Association states in June 1 comments to the Institute of Medicine division.

You may also be interested in...



IoM Omega-3 Fatty Acid DRI Recommendations Criticized By CRN

The 1Institute of Medicine's report on macronutrient Dietary Reference Intakes contains "unacceptably low" recommendations for the omega-3 fatty acids EPA and DHA, the Council for Responsible Nutrition asserts

Fiber

IoM Food & Nutrition Board will accept comments on its proposed definitions of fiber until May 31, after which it will establish final definitions that will appear in upcoming report setting dietary reference intakes for macronutrients; report is due out by year-end. Proposed definitions distinguish between: dietary fiber, "non-digestible carbohydrates and lignin that are intrinsic and intact in plants"; added fiber, "isolated, non-digestible carbohydrates that have beneficial physiological effects in humans"; and total fiber, "the sum of dietary fiber and added fiber." Comments may be mailed to FNB or emailed to [email protected]

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS131877

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel